Related Experiment Video

Updated: Mar 25, 2026

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
06:29

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay

Published on: March 1, 2011

27.1K

Influence of Interleukin-1 Beta on Platelet-Poor Plasma Clot Formation: A Potential Impact on Early Bone Healing

Xin Wang1,2,3,4, Yan Luo2,3, Paul P Masci4

  • 1Department of Spine, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou Province, China.

Plos One
|February 25, 2016
PubMed
Abstract

Insights

Interleukin-1 beta (IL-1β) alters fibrin clot structure in platelet-poor plasma (PPP), impacting bone healing. This study shows IL-1β accelerates protofibril formation and increases fibrin clot density.

Area of Science:

  • Biochemistry
  • Biomaterials Science
  • Regenerative Medicine

Background:

  • Hematoma quality, particularly the fibrin matrix, is crucial for bone healing.
  • Interleukin-1 beta (IL-1β) is a key inflammatory cytokine involved in healing processes.

Purpose of the Study:

  • To investigate the impact of IL-1β on fibrin clot formation from platelet-poor plasma (PPP).
  • To understand how IL-1β influences the structural properties of fibrin clots relevant to bone healing.

Main Methods:

  • Rat whole blood was collected, and platelet-poor plasma (PPP) was isolated.
  • Fibrin clot formation was induced with varying concentrations of IL-1β.
  • Fibrin structure was analyzed using scanning electron microscopy (SEM), confocal microscopy (CM), turbidity measurements, and clot lysis assays.

Main Results:

  • IL-1β significantly shortened the lag time for protofibril formation.
  • Higher concentrations of IL-1β (500 pg/mL) reduced fibrin fiber diameter, decreased pore size, and increased clot density.
  • IL-1β treatment resulted in fibrin clots with lower susceptibility to dissolution.

Conclusions:

  • IL-1β markedly influences the structural characteristics of fibrin clots formed from PPP.
  • These structural changes induced by IL-1β may play a significant role in modulating the early stages of bone healing.

More Related Videos

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.8K
Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

18.7K

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.6K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.6K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K